Brought to you by
Book your space
Neutralizing antibodies bind at or near the active site of the drug molecule and neutralize its functional activity. For therapeutic neutralizing antibodies, their functional activities are evaluated from screening, research and development, production and product release.
Due to advances in basic theory and technology, these methods are updated rapidly.
This webinar discusses the approaches used to screen for SARS-CoV-2 (2019-nCoV) neutralizing antibodies and evaluate their bioactivity in vitro.
By attending this webinar, you will learn: